New-onset systemic sclerosis and scleroderma renal crisis under docetaxel

Systemic sclerosis is a rare systemic autoimmune disease characterized by microvascular impairment and fibrosis of the skin and other organs with poor outcomes. Toxic causes may be involved. We reported the case of a 59-year-old woman who developed an acute systemic sclerosis after two doses of adju...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Journal of scleroderma and related disorders Ročník 6; číslo 3; s. 306
Hlavní autori: Debien, Véronique, Petitdemange, Arthur, Bazin, Dorothée, Ederle, Carole, Nespola, Benoit, Merdji, Hamid, Olagne, Jérome, Martin, Thierry, Guffroy, Aurélien, Pflumio, Carole
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England 01.10.2021
Predmet:
systemic sclerosis
paraneoplastic
chemotherapy
drug-induced autoimmune disease
scleroderma
Docetaxel
ISSN:2397-1991, 2397-1991
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Systemic sclerosis is a rare systemic autoimmune disease characterized by microvascular impairment and fibrosis of the skin and other organs with poor outcomes. Toxic causes may be involved. We reported the case of a 59-year-old woman who developed an acute systemic sclerosis after two doses of adjuvant chemotherapy by docetaxel and cyclophosphamide for a localized hormone receptor + human epithelial receptor 2-breast cancer. Docetaxel is a major chemotherapy drug used in the treatment of breast, lung, and prostate cancers, among others. Scleroderma-like skin-induced changes (morphea) have been already described for taxanes. Here, we report for the first time a case of severe lung and kidney flare with thrombotic microangiopathy after steroids for acute interstitial lung disease probably induced by anti-RNA polymerase III + systemic sclerosis after docetaxel.
Bibliografia:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:2397-1991
2397-1991
DOI:10.1177/23971983211007669